Managing Atopic Dermatitis in Patients With Skin of Color
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Raj J. Chovatiya, associate professor at Rosalind Franklin University of Medicine and Science Chicago Medical School, about diagnosing and treating atopic dermatitis in patients with darker skin tones. Learn what he tells his trainees about diagnosing atopic dermatitis in skin of color. Find out how a greater understand …
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Raj J. Chovatiya, associate professor at Rosalind Franklin University of Medicine and Science Chicago Medical School, about diagnosing and treating atopic dermatitis in patients with darker skin tones. Learn what he tells his trainees about diagnosing atopic dermatitis in skin of color. Find out how a greater understand … Continue reading "Managing Atopic Dermatitis in Patients With Skin of Color"
The past 18 months has seen an unprecedented wave of FDA approvals in dermatology, significantly expanding the therapeutic options for treatment of inflammatory skin diseases. At the 2025 Skin Of Color Update in New York City, conference co-chair Dr. Andrew Alexis highlighted some of these new medications and new indications for others. Importantly, many of these pivotal clinical trials includ … 
Bimatoprost is a prostaglandin analog originally developed for glaucoma that has become an important tool in dermatology for the treatment of eyelash and eyebrow hypotrichosis. By prolonging the anagen phase of hair growth, bimatoprost enhances lash length, thickness, and pigmentation. We continue our Therapeutic Cheat Sheet series with a closer look at bimatoprost.
Bimatoprost Therapeutic Cheat … 
Topical corticosteroids have been a mainstay of frontline therapy for atopic dermatitis (AD) for more than half a century. Now therapeutic advances are challenging that standard of care. Nonsteroidal topicals -- topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE-4 inhibitors -- are expanding pathways of addressing the signs and symptoms of AD.
An article in the March Journal … 
What histologic features are typically seen on a skin biopsy of this lesion?
A. Necrobiotic degeneration of dermal collagen surrounded by an inflammatory reaction
B. Layers with open-ended necrobiotic foci; lack of mucin; increased numbers of plasma cells (necrobiosis lipoidica)
C. Larger areas of eosinophilic necrobiosis and a lack of mucin deposition (rheumatoid nodule)
D. Immuno …